Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Lachance

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of GlioblastomaRachael A Vaubel, Shulan Tian, Dioval Remonde, et al.
Nature Genetics|August 28, 2012
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationRobert B Jenkins, Yuanyuan Xiao, Hugues Sicotte, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
Neuro-Oncology|August 21, 2018
Sex-specific gene and pathway modeling of inherited glioma riskQuinn T Ostrom, Warren Coleman, William Huang, et al.
Scientific Reports|May 11, 2018
Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21Quinn T Ostrom, Ben Kinnersley, Margaret R Wrensch, et al.
Neuro-Oncology Practice|May 14, 2026
Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based surveyFrancis Zerd, Lateef A Odukoya, Beverly Cheserem, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Human Genetics|August 14, 2012
Genome-wide association study of glioma and meta-analysisPreetha Rajaraman, Beatrice S Melin, Zhaoming Wang, et al.
Nature Genetics|September 28, 2011
A germline variant in the TP53 polyadenylation signal confers cancer susceptibilitySimon N Stacey, Patrick Sulem, Aslaug Jonasdottir, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of GlioblastomaRachael A Vaubel, Shulan Tian, Dioval Remonde, et al.
Nature Genetics|August 28, 2012
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutationRobert B Jenkins, Yuanyuan Xiao, Hugues Sicotte, et al.
The New England Journal of Medicine|June 11, 2015
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in TumorsJeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, et al.
Neuro-Oncology|August 21, 2018
Sex-specific gene and pathway modeling of inherited glioma riskQuinn T Ostrom, Warren Coleman, William Huang, et al.
Scientific Reports|May 11, 2018
Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21Quinn T Ostrom, Ben Kinnersley, Margaret R Wrensch, et al.
Neuro-Oncology Practice|May 14, 2026
Evaluating the current neuro-oncology capacity in Sub-Saharan Africa: A questionnaire-based surveyFrancis Zerd, Lateef A Odukoya, Beverly Cheserem, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Human Genetics|August 14, 2012
Genome-wide association study of glioma and meta-analysisPreetha Rajaraman, Beatrice S Melin, Zhaoming Wang, et al.
Nature Genetics|September 28, 2011
A germline variant in the TP53 polyadenylation signal confers cancer susceptibilitySimon N Stacey, Patrick Sulem, Aslaug Jonasdottir, et al.
Pageof 9